Omar R Shakir, MD, MBA
600 W Putnam Ave
Lower Level
Greenwich, CT 06830
United States map
Info@coastaleyesurgeons.com
www.coastaleyesurgeons.com
(203) 900-4011 office
https://www.linkedin.com/in/dromarshakir
Professional Affiliations
Academic Appointments- Clinical Instructor at Yale University
- Greenwich Hospital
- Stamford Hospital
- Yale New Haven Hospital
Education and Training
- Retinal fellowship
- Yale University School of Medicine, Yale University Dept of Ophthalmology, New Haven, CT, USA
- Ophthalmology residency
- University of Florida-Jacksonville, University of Florida, College of Medicine, Jacksonville, FL, USA
- Internship
- Johns Hopkins Medical Institutions, Johns Hopkins School of Medicine, Baltimore, MD, USA
- Medical School
- Albany Medical College, Albany, NY, USA
- College
- Union College, Schenectady, NY, USA
- College
- Clarkson University School of Business, Schenectady, NY, USA
Biography
Omar Shakir, MD, MBA, is a highly distinguished vitreoretinal surgeon and a pioneering force in the advancement of modern retina care. As Founder and Medical Director of Coastal Eye, Dr. Shakir directs a high-volume, state-of-the-art retina practice renowned for delivering elite surgical outcomes.
Trained at the prestigious Yale University School of Medicine, where he currently serves as a Clinical Instructor teaching the next generation of retina fellows, Dr. Shakir is armed with exceptional, complex vitreoretinal surgical skills. He is widely recognized for his trailblazing work in office-based retina surgery, successfully transitioning advanced procedures to a modernized, patient-centric setting. He is also a leading authority on 27-gauge pars plana vitrectomy for visually significant floaters, championing definitive surgical intervention to restore visual quality, particularly for younger individuals suffering from debilitating vitreous opacities.
At the forefront of ophthalmic innovation, Dr. Shakir is the Founder and Principal Investigator of SightSERA Clinical Research. Under his leadership, he directs over 20 Phase 2 through Phase 4 clinical trial programs, accelerating the development of groundbreaking therapeutics and treatments for complex retinal diseases.
As a prominent Key Opinion Leader (KOL) and strategic advisor to the industry's top retina companies, Dr. Shakir serves on the Medical Advisory Board for VisionMed and collaborates closely with leaders like Alcon. Expanding his structural impact on the field, he is also Co-Founder and CMO of Retina Alliance, a specialized organization empowering independent retina practices nationwide.
A highly sought-after speaker, Dr. Shakir regularly shares his surgical expertise and clinical insights from the podium at premier academic meetings, including the AAO, ASCRS, and ARVO. Through his relentless commitment to surgical excellence, pioneering research, and fellow education, Dr. Shakir continues to redefine the standard of care in vitreoretinal surgery.